Polyplus Transfection, a company specialised in the transfer of genetic material into human cells, has invested in a new production site and plans to recruit 100 employees within three years. This investment of €30 million in three years will enable it to expand from a site of a few hundred to 4,000 sqm. The aim is to keep pace with the growth in turnover, which has increased by 70% a year over the last five years. The work, started in the spring of 2020, will allow a first move in the summer of 2021 and will be completed in 2023 with the delivery of a new factory. This investment will increase Polyplus' production capacity tenfold.